《美股业绩》挪威游轮季度亏损收窄 料无法七 月在美国复航
游轮营运商挪威游轮(NCLH.US)公布首季业绩。季度亏损13.7亿美元,按年收窄27.2%,主要因为对上年度同期录16.08亿美元减值。每股季度亏损4.16美元。季度收入310万美元,对上年度同期收入12.47亿美元。
公司表示,美国疾控中心(CDC)允许游轮於今年夏季复航,但公司游轮将因未能符合严格要求,无法在7月或8月在美国复航。行政总裁Frank Del Rio批评当局指引严苛,较对其他行业要求更严格。
公司早前宣布将在7月起,恢复希腊、西班牙、意大利、多米尼加共和国及牙买加的游轮业务。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.